Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2004 | 06-2003 | 06-2002 | 06-2001 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 0 | -3,440 | -2,800 |
| Depreciation Amortization | 0 | 0 | 0 | 3,460 | 280 |
| Other Working Capital | 0 | 0 | 0 | -80 | 350 |
| Other Operating Activity | -5,270 | -990 | -3,310 | -2,160 | 1,860 |
| Operating Cash Flow | $-5,270 | $-990 | $-3,310 | $-2,220 | $-310 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -790 | -200 | -90 | -70 | -2 |
| Net Acquisitions | 0 | 0 | 300 | -190 | -870 |
| Other Investing Activity | 820 | 490 | 9,110 | 1,840 | 1,752 |
| Investing Cash Flow | $30 | $290 | $9,320 | $1,580 | $880 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10,890 | 10 | 520 | -10 | 0 |
| Financing Cash Flow | $10,890 | $10 | $520 | $-10 | $0 |
| Exchange Rate Effect | -110 | -640 | -20 | 70 | 10 |
| Beginning Cash Position | 5,820 | 7,160 | 640 | 1,220 | 650 |
| End Cash Position | 11,360 | 5,820 | 7,160 | 640 | 1,220 |
| Net Cash Flow | $5,530 | $-1,330 | $6,510 | $-580 | $570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,270 | -990 | -3,310 | -2,220 | -310 |
| Free Cash Flow | -5,270 | -990 | -3,310 | -2,220 | -310 |